Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling

Oncogene

Volumn 34, Issue 7, 2015, Pages 838-845

  Hasegawa, Y ^a   Takahashi, M ^a   Ariki, S ^a   Asakawa, D ^b   Tajiri, M ^b   Wada, Y ^b   Yamaguchi, Y ^c   Nishitani, C ^a   Takamiya, R ^a   Saito, A ^a   Uehara, Y ^a   Hashimoto, J ^a   Kurimura, Y ^a   Takahashi, H ^a   Kuroki, Y ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; SURFACTANT PROTEIN D; CALCIUM; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR PROTEIN;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING ASSAY; CANCER CELL CULTURE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG ADENOCARCINOMA; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STABLE EXPRESSION; ANIMAL; CHO CELL LINE; CRICETULUS; DOWN REGULATION; GENETICS; HAMSTER; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CALCIUM; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84927171843     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.20     Document Type: Article

References (49)

1. Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. New Engl J Med 2002;347:2141-2148.
2. Kuroki Y, Takahashi M, Nishitani C. Pulmonary collectins in innate immunity of the lung. Cell Microbiol 2007;9:1871-1879.
3. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005;5:58-68.
4. Kingma PS, Whitsett JA. In defense of the lung: surfactant protein A and surfactant protein D. Curr Opin Pharmacol 2006;6:277-283.
5. Sahly H, Ofek I, Podschun R, Brade H, He Y, Ullmann U et al. Surfactant protein D binds selectively to Klebsiella pneumoniae lipopolysaccharides containing mannose-rich O-antigens. J Immunol 2002;169:3267-3274.
6. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003;111:1589-1602.
7. Ariki S, Kojima T, Gasa S, Saito A, Nishitani C, Takahashi M et al. Pulmonary collectins play distinct roles in host defense against Mycobacterium avium. J Immunol 2011;187:2586-2594.
8. Restrepo CI, Dong Q, Savov J, Mariencheck WI, Wright JR. Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol 1999;21:576-585.
9. Kudo K, Sano H, Takahashi H, Kuronuma K, Yokota S, Fujii N et al. Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor. J Immunol 2004;172:7592-7602.
10. Ohya M, Nishitani C, Sano H, Yamada C, Mitsuzawa H, Shimizu T et al. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide. Biochemistry 2006;45:8657-8664.
11. Nie X, Nishitani C, Yamazoe M, Ariki S, Takahashi M, Shimizu T et al. Pulmonary surfactant protein D binds MD-2 through the carbohydrate recognition domain. Biochemistry 2008;47:12878-12885.
12. Yamazoe M, Nishitani C, Takahashi M, Katoh T, Ariki S, Shimizu T et al. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J Biol Chem 2008;283:35878-35888.
13. Lin Z, Thomas NJ, Bibikova M, Seifart C, Wang Y, Guo X et al. DNA methylation markers of surfactant proteins in lung cancer. Int J Oncol 2007;31:181-191.
14. Ishii T, Hagiwara K, Ikeda S, Arai T, Mieno MN, Kumasaka T et al. Association between genetic variations in surfactant protein d and emphysema, interstitial pneumonia, and lung cancer in a Japanese population. COPD 2012;9:409-416.
15. Sin DD, Man SF, McWilliams A, Lam S. Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancer. Chest 2008;134:582-588.
16. Dawson JP, Bu Z, Lemmon MA. Ligand-induced structural transitions in ErbB receptor extracellular domains. Structure 2007;15:942-954.
17. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2:127-137.
18. Oxnard GR, Arcila ME, Chmielecki J, Ladanyi M, Miller VA, Pao W. New strategies in overcoming acquired resistance to epidermal growth factorreceptor tyrosine kinase inhibitors in lung cancer. Clin Cancer Res 2011;17:5530-5537.
19. Hrustanovic G, Lee BJ, Bivona TG. Mechanisms of resistance to EGFR targeted therapies. Cancer Biol Ther 2013;14:304-314.
20. Macdonald JL, Pike LJ. Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system. Proc Natl Acad Sci USA 2008;105:112-117.
21. Alvarado D, Klein DE, Lemmon MA. Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell 2010;142:568-579.
22. Soderquist AM, Carpenter G. Glycosylation of the epidermal growth factorreceptor in A-431 cells. The contribution of carbohydrate to receptor function. J Biol Chem 1984;259:12586-12594.
23. Bremer EG, Schlessinger J, Hakomori S. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factorreceptor. J Biol Chem 1986;261:2434-2440.
24. Tsuda T, Ikeda Y, Taniguchi N. The Asn-420-linked sugar chain in human epidermal growth factorreceptor suppresses ligand-independent spontaneous oligomerization. Possible role of a specific sugar chain in controllable receptor activation. J Biol Chem 2000;275:21988-21994.
25. Sato Y, Takahashi M, Shibukawa Y, Jain SK, Hamaoka R, Miyagawa Ji et al. Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors. J Biol Chem 2001;276:11956-11962.
26. Wang XQ, Sun P, O'Gorman M, Tai T, Paller AS. Epidermal growth factorreceptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation. Glycobiology 2001;11:515-522.
27. Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004;306:120-124.
28. Yoon SJ, Nakayama K, Hikita T, Handa K, Hakomori SI. Epidermal growth factorreceptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc Natl Acad Sci USA 2006;103:18987-18991.
29. Kawashima N, Yoon SJ, Itoh K, Nakayama K. Tyrosine kinase activity of epidermal growth factorreceptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions. J Biol Chem 2009;284:6147-6155.
30. Smith KD, Davies MJ, Bailey D, Renouf DV, Hounsell EF. Analysis of the glycosylation patterns of the extracellular domain of the epidermal growth factorreceptor expressed in Chinese hamster ovary fibroblasts. Growth Factors 1996;13:121-132.
31. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavagefluids. Am J Respir Crit Care Med 1995;152:1860-1866.
32. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000;161:5-8.
33. Aubry MC, Myers JL, Douglas WW, Tazelaar HD, Washington Stephens TL, Hartman TE et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin Proc 2002;77:763-770.
34. Park J, Kim DS, Shim TS, Lim CM, Koh Y, Lee SD et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001;17:1216-1219.
35. Betz C, Papadopoulos T, Buchwald J, Dämmrich J, Müller-Hermelink HK. Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lungcarcinomas: detection by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:4283-4286.
36. Takahashi H, Kuroki Y, Honda Y, Shijubo N, Hirasawa M, Fujishima T et al. Lipid analysis and surfactant-associated protein expression in lung adenocarcinoma cells from pleural effusion. Respiration 1996;63:390-396.
37. Qi ZL, Xiao L, Gao YT, Du JM, Jing L. Expression and clinical significance of surfactant protein D mRNA in peripheral blood of lung cancer patients. Ai Zheng 2002;21:772-775.
38. Mason RJ, Kalina M, Nielsen LD, Malkinson AM, Shannon JM. Surfactant protein C expression in urethane-induced murine pulmonary tumors. Am J Pathol 2000;156:175-182.
39. Zhang F, Pao W, Umphress S, Jakowlew S, Meyer AM, Dwyer-Nield LD et al. Serum levels of surfactant protein D are increased in mice with lung tumors. Chest 2004;125:109S.
40. Bastacky J, Lee CY, Goerke J, Koushafar H, Yager D, Kenaga L et al. Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol 1995;79:1615-1628.
41. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986;60:532-538.
42. Tino MJ, Wright JR. Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages. Am J Physiol 1999;276:L164-L174.
43. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997;77:931-962.
44. Nagae H, Takahashi H, Kuroki Y, Honda Y, Nagata A, Ogasawara Y et al. Enzymelinked immunosorbent assay using F (ab') 2 fragment for the detection of human pulmonary surfactant protein D in sera. Clin Chim Acta 1997;266:157-171.
45. Sawada K, Ariki S, Kojima T, Saito A, Yamazoe M, Nishitani C et al. Pulmonary collectins protect macrophages against pore-forming activity of Legionella pneumophila and suppress its intracellular growth. J Biol Chem 2010;285:8434-8443.
46. Takahashi M, Hasegawa Y, Ikeda Y, Wada Y, Tajiri M, Ariki S et al. Suppression of heregulin beta signaling by the single N-glycan deletion mutant of soluble ErbB3 protein. J Biol Chem 2013;288:32910-32921.
47. Wada Y, Tajiri M, Yoshida S. Hydrophilic affinity isolation and MALDI multiplestage tandem mass spectrometry of glycopeptides for glycoproteomics. Anal Chem 2004;76:6560-6565.
48. Tajiri M, Yoshida S, Wada Y. Differential analysis of site-specific glycans on plasma and cellular fibronectins: application of a hydrophilic affinity method for glycopeptide enrichment. Glycobiology 2005;15:1332-1340.
49. Tajiri M, Kadoya M, Wada Y. Dissociation profile of protonated fucosyl glycopeptides and quantitation of fucosylation levels of glycoproteins by mass spectrometry. J Proteome Res 2009;8:688-693.